Literature DB >> 8652778

Relationships between chemical characteristics and anticomplementary activity of fucans.

C Blondin1, F Chaubet, A Nardella, C Sinquin, J Jozefonvicz.   

Abstract

We have shown previously that a low-molecular-weight fucan extracted from the brown seaweed Ascophylum nodosum strongly inhibited human complement activation in vitro and its mechanism of action was largely elucidated. We further investigated the influence of molecular weight and chemical composition of fucan on its anticomplementary activity. The capacity of 12 fragments of fucan (ranging from a molecular weight of 4100 to 214,000) to prevent complement-mediated haemolysis of sheep erythrocytes (classical pathway) and of rabbit erythrocytes (alternative pathway) increased with increasing molecular weight, and reached a plateau for 40,000 and 13,500, respectively. The most potent fucan fractions were 40-fold more active than heparin in inhibiting the classical pathway. They were, however, as active as heparin in inhibiting the alternative pathway. In addition, we have developed a haemolytic test based on the CH50 protocol, which allows discrimination between activators and inhibitors of complement proteins. Although the mannose content within the different fucan fragments did not vary, the galactose and glucuronic acid contents increased with increasing activity, suggesting that these residues should be essential for full anticomplementary activity. Meanwhile, sulphate groups appeared to be necessary, but were clearly not a sufficient requirement for anticomplementary activity of fucans. Taken together, these data illustrate the prospects for the use of fucans as potential anti-inflammatory agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8652778     DOI: 10.1016/0142-9612(96)88710-2

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  10 in total

1.  Inhibitory effects of Fucoidan in 3T3-L1 adipocyte differentiation.

Authors:  Mi-Ja Kim; Un-Jae Chang; Jin-Sil Lee
Journal:  Mar Biotechnol (NY)       Date:  2008-12-10       Impact factor: 3.619

2.  Neuroprotective effect of fucoidan on H2O2-induced apoptosis in PC12 cells via activation of PI3K/Akt pathway.

Authors:  Yonglin Gao; Chaohua Dong; Jungang Yin; Jingyu Shen; Jingwei Tian; Chunmei Li
Journal:  Cell Mol Neurobiol       Date:  2012-01-06       Impact factor: 5.046

3.  Structural characterization of a homogalacturonan from Capparis spinosa L. fruits and anti-complement activity of its sulfated derivative.

Authors:  Huijun Wang; Hongwei Wang; Songshan Shi; Jinyou Duan; Shunchun Wang
Journal:  Glycoconj J       Date:  2012-07-01       Impact factor: 2.916

Review 4.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

5.  Structural analysis and anti-complement activity of polysaccharides from Kjellmaniella crsaaifolia.

Authors:  Wenjing Zhang; Weihua Jin; Delin Sun; Luyu Zhao; Jing Wang; Delin Duan; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-03-16       Impact factor: 5.118

6.  The Structure-Activity Relationship between Marine Algae Polysaccharides and Anti-Complement Activity.

Authors:  Weihua Jin; Wenjing Zhang; Hongze Liang; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-12-25       Impact factor: 5.118

7.  Oral Single Dose Toxicity Study of Low Molecular Fucoidan in Mice.

Authors:  Young-Mi Jung; Kang Min Yoo; Dong-Chan Park; Tae-Kwon Kim; Hyeung-Sik Lee; Sae-Kwang Ku
Journal:  Toxicol Res       Date:  2008-03-01

8.  Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathway.

Authors:  Anthony Courtois; Christelle Simon-Colin; Claire Boisset; Christian Berthou; Eric Deslandes; Jean Guézennec; Anne Bordron
Journal:  Mar Drugs       Date:  2008-07-10       Impact factor: 5.118

9.  Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system.

Authors:  Anthony Courtois; Christian Berthou; Jean Guézennec; Claire Boisset; Anne Bordron
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 10.  Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.

Authors:  Alexa Klettner
Journal:  Mar Drugs       Date:  2016-02-03       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.